Serum leptin in male hypothyroid prediabetic patients: Association with cardiovascular risk

Hanaa T El-Zawawy1

  • 1Department of Internal Medicine, Endocrinology Unit, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Insights

Serum leptin is elevated in hypothyroidism, regardless of prediabetes. In hypothyroid prediabetic patients, leptin correlates with metabolic syndrome markers, suggesting it may predict coronary heart disease risk.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Disorders

Background:

  • Hypothyroidism and prediabetes are independent risk factors for cardiovascular disease.
  • Hyperleptinemia is linked to coronary heart disease (CHD).
  • Limited research exists on leptin's role in hypothyroid patients with prediabetes and its impact on CHD risk factors.

Purpose of the Study:

  • To determine serum leptin levels in hypothyroid prediabetic patients.
  • To investigate the relationship between serum leptin and CHD risk factors in this population.

Main Methods:

  • A comparative study involving 120 hypothyroid males with normal glucose tolerance (Group A), 120 hypothyroid males with prediabetes (Group B), and 120 healthy controls (Group C).
  • Assessment included clinical examination and laboratory tests: blood glucose, lipid profile (TC, TG, LDL, HDL), thyroid hormones (free T3, free T4, TSH), and serum leptin.

Main Results:

  • Serum leptin was significantly elevated in both hypothyroid groups (A and B) compared to controls (P=0.0001).
  • Hypothyroid prediabetic patients (Group B) exhibited higher total cholesterol (TC), low-density lipoprotein (LDL), and lower high-density lipoprotein (HDL) compared to hypothyroid patients without prediabetes (Group A).
  • In Group B, serum leptin showed positive correlations with TC, triglycerides (TG), and LDL, and a negative correlation with HDL.

Conclusions:

  • Elevated serum leptin in hypothyroidism is independent of prediabetic status.
  • Serum leptin in hypothyroid prediabetic patients is associated with key metabolic syndrome markers.
  • Leptin may serve as a predictive marker for the development of CHD in individuals with hypothyroidism and prediabetes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
531
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
505
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
358
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
287
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
837
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
427